EBAMed

We are delighted that our CEO is being invited to such prestigious meetings, reflecting our commitment to innovation and leadership in advancing patient care.

Come and discover how EBAMed is leading the way in innovation for cardiac care! Looking forward to seeing you there.

❤️🔬 Heart Health Innovations Unveiled! Join us for the 'Advanced Technologies Panel: Focusing on CardioTech Innovation' at the #Sachs_HTIF on September 24th, 2024, at the Mövenpick Hotel Basel. Dive into the latest breakthroughs in cardiovascular technology that are setting new standards for patient care. Co-Chaired by: Diana Saraceni, Co-Founder & General Partner, Panakes Partners SGR SpA Isaac Middelmann, Accelerator Director - Strategic Fundraising, EIT Health e.V. Panellists: Filippo Piatti, Co-Founder & CEO, Artiness S.r.l Jean-Pierre Pennacino, CFO, MedAlliance Swiss Medical Technology SA Marina Izzo, CEO, EBAMed SA Nitzan Hirsh, Co-Founder & CEO, LuSeed Vascular Roman Schenk, Managing Partner, INOGROUP GmbH This panel will explore the frontier of CardioTech, showcasing how advanced technologies are transforming cardiac care. Hear from leading experts about new devices, diagnostics, and digital health solutions that are improving outcomes for heart disease patients. Discover the impact of these innovations on clinical practice and patient management. Don’t miss this opportunity to see how technology is reshaping heart health. Secure your spot today at www.sachsforum.com/11htif and join us, both #inperson & #online, during the Sachs Autumn Life Sciences Week. #CardioTech #HeartHealth #MedicalDevices #HealthTech #DigitalHealth #InnovationInHealthcare #Sachs_HTIF #SALSW

The true impact of Cardiac Radio Ablation is best illustrated through the voices of the patients whose lives it has transformed. https://lnkd.in/eGz-nqr2

STAR is a groundbreaking, noninvasive solution for treating malignant ventricular arrhythmias. Experts agree that safety margins for the cardiac target volume (CardTV) must be meticulously defined to protect healthy heart tissue. Radiation oncologists are urged to minimize unnecessary margins, ensuring that only the arrhythmia-affected areas are targeted, preserving the heart’s vital, functioning myocardium. https://lnkd.in/eJtyirch

Several recent studies have assessed the structure displacements associated with cardiac motion, which are relevant for STAR. The STOPSTORM Consortium dedicated a journal club to this subject. Emerging data indicate a non-negligible impact of cardiac motion on radiotherapy delivery. Until active measures are available to mitigate these displacements, they suggest that radiotherapy planning margins should be considered for STAR. In this context, implementing gating techniques could significantly enhance treatment precision by synchronizing radiotherapy delivery with cardiac motion, reducing the need for larger planning margins and improving patient outcomes.

📅 Save the Date: September 24 Looking forward to sharing insights and discussing the latest innovations in health technology. Hope to see you there! #HealthTech #Innovation #CardioTech #InvestmentForum

🚀 Excited to share the latest research on Gated Pencil Beam Scanning for Cardiac Radiation-Ablation presented at the PTCOG24 Congress! 📊🔬 Discover how ultrasound-based dual-gating effectively mitigates cardio-respiratory motion in cardiac treatments. Join us in advancing VT Therapy! #CardiacRadioTherapy #NonInvasiveAblation #SafetyFirst Congratulations to Kyung-Wook Jee, Evan Driscoll, Ethan Cascio, Maozhong Zhou, Nicolas Depauw, Konrad Nesteruk, Adriano Garonna, Willian Nett, Steve Bradley, Benjamin Clasie PhD from Mass General Brigham / Harvard Medical School,  Pyramid Technical Consulting & EBAMed

Cardiorespiratory-gated cardiac radiotherapy using a novel ultrasound guidance system - EBAMed Animation

Today, we want to celebrate the new data presented at the European Society for Radiotherapy and Oncology (ESTRO) 2024 Congress, suggesting that EBAMed's gated cardiac radiotherapy will provide reduced irradiation volumes and increase tissue sparing during Cardiac Radioablation procedures. Congratulations to Keith Cengel, Michele Kim, Sarah Hagan, Tara Oster, Eric Diffenderfer, Cory Tschabrunn and Weihow Hsue, DVM, DACVIM (Cardiology) at University of Pennsylvania Philadelphia for reaching this milestone and completing our first pre-clinical study! Kudos to the EBAMed team, including Saskia Camps, Alexander Kalinin, Adriano Garonna, and to the IBA team, for their support in characterizing the response times to gating commands for the University of Pennsylvania ProteusPlus system. #CardioKitMVP achieves Proof-of-Concept milestone! #TeamWork #Innovation